Alpha Paradigm Partners’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.01M Buy
+85,344
New +$975K 0.42% 69
2022
Q3
Sell
-7,743
Closed -$77K 474
2022
Q2
$77K Sell
7,743
-15,563
-67% -$314K 0.03% 421
2022
Q1
$804K Sell
23,306
-8,880
-28% -$288K 0.32% 82
2021
Q4
$1.6M Buy
32,186
+6,929
+27% +$365K 0.64% 23
2021
Q3
$1.16M Buy
25,257
+20,898
+479% +$828K 0.47% 49
2021
Q2
$130K Sell
4,359
-40,656
-90% -$830K 0.05% 410
2021
Q1
$916K Buy
+45,015
New +$950K 0.36% 73

Other funds holding ASPN

Alpha Paradigm Partners's ASPN Position: Q4 2022 in Review

Alpha Paradigm Partners opened a new position in Aspen Aerogels (ASPN) in Q4 2022: 85,344 shares worth $1.01M. The stake represents 0.42% of the portfolio and ranks #69 among its holdings. This is a return to the name: Alpha Paradigm Partners previously reported a position in ASPN as recently as Q2 2022.

Alpha Paradigm Partners first reported a position in ASPN in Q1 2021 and has held it in 7 quarters since. The position peaked at $1.6M in Q4 2021. 164 funds tracked by Wall St. Rank hold ASPN as of Q4 2022.

  • Alpha Paradigm Partners held 85,344 shares of Aspen Aerogels worth $1.01M as of Q4 2022.
  • Aspen Aerogels was a new Alpha Paradigm Partners position in Q4 2022.
  • Aspen Aerogels made up 0.42% of Alpha Paradigm Partners's portfolio in Q4 2022, its #69 holding.
  • Alpha Paradigm Partners first reported a position in Aspen Aerogels in Q1 2021 and has held it in 7 quarters since.
  • Alpha Paradigm Partners's Aspen Aerogels position peaked at $1.6M in Q4 2021.
  • 164 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2022.

Based on Alpha Paradigm Partners's 13F filing for Q4 2022, filed 13 Feb 2023.